Abstract:Objective: The goal of this research was to purify and characterize the novel angiotensin-converting enzyme (ACE)-inhibitory and antioxidant peptides from fermented whey protein concentrate produced by Lactobacillus paracasei and Saccharomyces cerevisiae in a co-fermentation system. Method: Whey protein fermented with lactic acid bacteria and yeast culture was analyzed for antioxidative, ACE inhibition, as well as anti-inflammatory activity followed by SDS-PAGE, isoelectric focusing, and 2-dimensional (2D) analysis. Anti-inflammatory activity of whey protein fermentate was also studied on the RAW 264.7 cell line. The bioactive peptides were separated from the whey protein fermentate using reverse-phase high-performance liquid chromatography (RP-HPLC) and reverse-phase liquid chromatography mass spectrometry (RPLC/MS), and thus identification and characterization of purified bioactive peptide was performed. Results: Whey protein fermentate samples' bioactivity was analyzed at specific time intervals at 12, 24, 36, and 48 hours at 37 °C for M11 and at 25 °C for WBS2A. The development settings (incubation time [12, 24, 36, and 48 hours) and inoculation rates [1.5%, 2.0%, and 2.5%]) were optimized for peptide synthesis via the o-phthaldialdehyde (OPA) method (proteolytic activity). Maximum proteolytic activity was observed at 37 °C for M11 (6.50 mg/mL) and at 25 °C for WBS2A (8.59 mg/mL) for 48 hours of incubation. Protein profiling was carried out using SDS-PAGE and 2D gel electrophoresis, in which Sodium dodecyl-sulfate (SDS) exhibited protein bands in the 10- to 55-kDa range, while 2D showed protein bands varying from 10 to 70 kDa. Every spot from 2D was digested by trypsin and identified by RPLC/MS. Protein fractionations (3- and 10-kDa permeates) were carried out employing RP-HPLC. Whey protein fermentate has anti-inflammatory action in RAW 264.7 macrophages that have been exposed to lipopolysaccharide. A molecular docking system was also used to investigate the interactions of peptides (AFLDSRTR, ILGAFIQIITFR) with human myeloperoxidase enzyme. Conclusions: The antihypertensive and antioxidative peptides discovered from whey protein fermentate may be helpful in the design of pharmacologically active healthy ingredients in the upcoming years.

Optimization of Sour Milk Fermentation for the Production of ACE-inhibitory Peptides and Purification of a Novel Peptide from Whey Protein Hydrolysate

Optimizing Fermentation Conditions of Lactobacillus helveticus for Preparing ACE Inhibitory Peptides from Whey Protein

Studies on Preparation of ACE Inhibitory Peptides Through Hydrolyzing of Casein by Enzymatic Membrane Reactor

Optimization of Fermentation Conditions for the Production of Angiotensin-Converting Enzyme (ACE) Inhibitory Peptides from Cow Milk by Lactobacillus bulgaricus LB6

Optimization of Hydrolysis Conditions for Production of Angiotensin-I Converting Enzyme(ACE)Inhibitory Peptide from Whey Protein Using Proteinases of Lactobacillus helveticus

Purification and Identification of Novel Peptides with Inhibitory Effect Against Angiotensin I-Converting Enzyme and Optimization of Process Conditions in Milk Fermented with the Yeast Kluyveromyces Marxianus

Optimisation of hydrolysis conditions for the production of the angiotensin-I converting enzyme (ACE) inhibitory peptides from whey protein using response surface methodology

Production and Transepithelial Transportation of Angiotensin-I-converting Enzyme (Ace)-Inhibitory Peptides from Whey Protein Hydrolyzed by Immobilized Lactobacillus Helveticus Proteinase.

Production and Fermentation Characteristics of Angiotensin-I-converting Enzyme Inhibitory Peptides of Goat Milk Fermented by a Novel Wild Lactobacillus Plantarum 69

Screening, Probiotic Properties Evaluation and Application of ACE-inhibitory Peptide-producing Lactic Acid Bacteria

Optimization of Nutrient Composition for Producing ACE Inhibitory Peptides from Goat Milk Fermented by Lactobacillus bulgaricus LB6

Optimization of Enzymatic Hydrolysis Technology of Casein by Proteinases from Lactobacillus Helveticus for ACE Inhibitory Peptide Production

Novel Angiotensin-Converting Enzyme-Inhibitory Peptides from Fermented Bovine Milk Started by Lactobacillus Helveticus KLDS.31 and Lactobacillus Casei KLDS.105: Purification, Identification, and Interaction Mechanisms

ACE-Inhibitory Activity of Whey Proteins Fractions Derived of Fermentation by Lacticaseibacillus rhamnosus GG and Streptococcus thermophilus SY-102

Production of Angiotensin I-Converting Enzyme Inhibitory Peptide from Goat Milk Casein: Optimization Conditions of Complex Protease Hydrolysate by Response Surface Methodology and Purification

ACE Inhibitory and Antioxidant Peptides from Alcalase‐assisted Lactiplantibacillus Plantarum L60 and Lacticaseibacillus Rhamnosus LR22 Fermentation of Goat Milk: Optimization and Identification

Purification and Characterization of Novel Antihypertensive and Antioxidative Peptides From Whey Protein Fermentate: In Vitro, In Silico, and Molecular Interactions Studies

Characterization of angiotensin-converting enzyme inhibitory activity of fermented milk produced by Lactobacillus helveticus

The preparation of bioactive peptides by fermentation and the hydrolyzates determination

Optimization Of Hydrolysis Conditions For The Production Of Angiotensin-I Converting Enzyme-Inhibitory Peptides And Isolation Of A Novel Peptide From Lizard Fish (Saurida Elongata) Muscle Protein Hydrolysate

Study of the Antioxidative Whey Protein Peptides by Microbe Fermenting